10-Q: Gyrodyne Extends Liquidation, Boosts Net Assets

Gyrodyne, LLC reports increased net assets and an extended liquidation timeline to 2027, driven by a new property sale agreement and ongoing entitlement efforts.

Summary

• Net assets in liquidation increased to $32,378,669 as of September 30, 2025, up from $30,596,313 at December 31, 2024.
• Estimated liquidating distributions per common share rose to $14.72 from $13.91, based on 2,199,308 shares outstanding.
• The increase in net assets is primarily due to a $4,502,000 increase in real estate value from the B2K Agreement and $280,500 from leasing activity, partially offset by increased liquidation costs.
• The estimated timeline for completing the liquidation has been extended to December 31, 2027, due to the B2K Agreement's contingencies.
• A Purchase and Sale Agreement was signed on July 30, 2025, with B2K Smithtown LLC for approximately 49 acres of Flowerfield vacant land, with an estimated value of $28,740,000, contingent on subdivision and site plan approvals.
• The company continues to vigorously defend against the Article 78 Proceeding challenging the Flowerfield Subdivision Application, with petitioners filing multiple appeals and motions that have been denied by the Supreme Court.
• Leasing activity for the nine months ended September 30, 2025, included 4 new leases and 6 renewals totaling 36,500 square feet, generating approximately $602,000 in annual revenue and $3.2 million in total commitments.
• An agreement with Star Equity Fund, LP was reached on October 16, 2025, resolving a proxy contest and leading to a reduction in the Board size from five to four directors.
• The company incurred approximately $311,000 in land entitlement costs during the nine months ended September 30, 2025, and anticipates an additional $1,142,000 through the end of the liquidation period.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While net assets and estimated distributions per share increased due to a significant property sale agreement, the liquidation timeline has been extended, and substantial legal and macroeconomic risks persist. The resolution of the proxy contest is a positive for corporate governance stability, but the overall process remains complex and uncertain.

Positives

• Net assets in liquidation increased by $1,782,356, leading to a higher estimated distribution per share.
• A Purchase and Sale Agreement for a significant portion of the Flowerfield property (49 acres) was secured with B2K Smithtown LLC, valued at an estimated $28,740,000.
• The Supreme Court of New York has repeatedly ruled in favor of the company, dismissing the Article 78 Petition and denying subsequent appeals and motions by petitioners.
• Successful leasing activity, including 4 new leases and 6 renewals, generated approximately $602,000 in annual revenue and $3.2 million in total commitments.
• Resolution of a proxy contest with Star Equity Fund, LP, leading to a cooperation agreement and board restructuring.
• The value of remaining unsold properties continues to exceed their 2014 appraised values, satisfying the terms of the 2015 class action lawsuit settlement.

Negatives

• The liquidation timeline has been extended to December 31, 2027, indicating a longer period until final distributions.
• Estimated liquidation and operating costs net of estimated receipts increased by $1,183,499 to $12,273,245, partly due to the timeline extension and increased real estate value.
• Cash and cash equivalents decreased to $5,106,711 from $5,899,232 at December 31, 2024.
• The B2K Agreement is subject to significant contingencies, including subdivision and site plan approvals, which may take years or not be obtained.
• The company expects to continue incurring operating losses and has a limited cash runway of approximately 18 months without further asset sales.
• Ongoing legal challenges from the Article 78 Proceeding continue to incur legal fees and potentially delay the Flowerfield property sale.
• Macroeconomic factors such as elevated interest rates, persistent inflation, and potential recession continue to weaken commercial real estate markets and constrain capital availability.
• Lingering effects of the COVID-19 pandemic continue to impact the timeliness of local government approvals and demand for commercial real estate.

Risks

• The sale of the Flowerfield property to B2K Smithtown LLC is contingent on receiving subdivision and site plan approval, which may take years or may not be obtained at all.
• The company expects to continue incurring operating losses and has limited cash resources, sufficient for approximately 18 months without further real estate sales.
• Ongoing legal proceedings, such as the Article 78 Proceeding, can be costly and time-consuming, disrupting operations and diverting management's attention, potentially delaying the strategic objective of property sales.
• Perceived uncertainties about the company's future direction due to legal challenges or activist shareholder actions may result in the loss or compromise of potential opportunities to liquidate properties for maximum value.
• A successful proxy contest could result in a change of control of the Board, potentially triggering contractual obligations under material agreements.
• If nominees advanced by activist shareholders with specific agendas are elected, it may adversely affect the ability to effectively and timely implement the strategic plan.
• Proxy contests may cause stock price volatility.
• The real estate market is cyclical, and property values are affected by capital availability, occupancy rates, rental rates, interest rates, and inflation, making real estate value determination uncertain.
• The company's ability to obtain required permits and authorizations for entitlements is subject to factors beyond its control, including environmental concerns, government backlogs, and labor shortages.
• There is no assurance that value enhancement efforts will result in property value increases that exceed the costs incurred, or any increase at all.
• The healthcare industry, to which the company has significant tenant exposure, is subject to substantial regulation, cost controls, and changes in reimbursement policies, which could impact tenants' ability to pay rent.
• Shareholders could be held liable for distributions and required to return funds if there are insufficient funds to pay creditors after liquidation.

Future Outlook

The company anticipates completing its liquidation process by December 31, 2027, with subdivision approval for Flowerfield expected in Q1 2026 and Cortlandt Manor in 2027. The sale of the 49-acre Flowerfield parcel to B2K Smithtown LLC is estimated to close by December 2027 or August 2028, contingent on regulatory approvals. The company plans to seek modifications to existing loan facilities to ensure adequate funding through the extended liquidation period. Management believes its strategy of pursuing entitlements will maximize property values and shareholder distributions, though there is no assurance that value enhancement efforts will exceed costs or result in any increase at all. The company will continue to aggressively market its properties and entertain offers for the acquisition of the company itself.

Management Comments

• "Our corporate strategy is to pursue entitlements on our two remaining properties, so that they can be sold to one or more developers with increased development flexibility at higher prices, thereby maximizing value and distributions."
• "Gyrodyne intends to dissolve after we complete the disposition of our assets, apply the proceeds to settle debts and claims, and then pay liquidating distributions to our shareholders."
• "Gyrodyne remains confident in its defense of the appeal, the motion to renew and reargue and the motion to appeal the denial of the Petitioners motion to stay enforcement of the order."
• "We anticipate that future purchase agreements for Flowerfield or Cortlandt or any portions thereof will similarly identify receipt of subdivision and site plan approval as conditions to closing which the Company believes can be pursued simultaneously rather than sequentially."
• "The Company is aggressively marketing its properties and intends to negotiate contracts in an effort to complete the process as soon as practicable with the ultimate timeline being largely dependent on factors outside the Companys control."
• "We remain committed to (1) enhancing the net value of Flowerfield and Cortlandt Manor to maximize the returns for our shareholders, (2) completing the disposition of our assets, (3) making timely distributions to our shareholders, (4) managing capital and liquidity, (5) mitigating risks relating to interest rates and real estate cycles and (6) completing the liquidation of the Company."

Industry Context

The company operates within the commercial real estate sector, specifically focusing on medical office and industrial properties in Suffolk and Westchester Counties, New York. The industry faces headwinds from elevated interest rates, persistent inflation, and constrained capital from lending institutions, contributing to continued weakness in commercial real estate markets. The shift towards remote working and telemedicine, a residual effect of the COVID-19 pandemic, has adversely impacted demand for office space, though medical office properties have shown more resilience. The healthcare industry, a significant tenant base for Gyrodyne, is subject to increasing regulation and cost controls, which could affect tenant stability and property marketability.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks. The company is in a unique liquidation phase, making direct comparisons challenging.
• The company's strategy of pursuing entitlements to increase development flexibility is a common approach in real estate development to maximize asset value, but the success and timeline are highly dependent on local regulatory environments and market conditions.
• The ongoing legal challenges (Article 78 Proceeding) are specific to the company's Flowerfield property and its local regulatory approvals, not a broad industry trend.

Management Changes

Corporate Governance

Legal Proceedings

• **Article 78 Proceeding (Flowerfield Subdivision Application):** Petitioners (Incorporated Village of Head of the Harbor and others) commenced a special proceeding on April 26, 2022, seeking to annul the Town of Smithtown Planning Board's preliminary approval of the Flowerfield Subdivision Application and its SEQRA findings statement. The company is vigorously defending the determinations. The Supreme Court of New York, Suffolk County, dismissed the Petition in its entirety on October 11, 2024. Petitioners filed a notice of appeal on October 28, 2024, and a motion to renew and reargue on November 12, 2024. The court denied the motion to stay enforcement on March 17, 2025, and denied the motion to renew and reargue on March 21, 2025. Petitioners filed another notice of appeal on April 16, 2025, and perfected their appeal on the original Petition on April 28, 2025. Gyrodyne filed its response on July 25, 2025, and the Town submitted its reply on July 28, 2025. The company remains confident in its defense, but the proceeding is expected to extend into 2027.
• **Putative Class Action Lawsuit (Settlement):** On August 14, 2015, the company settled a class action lawsuit, agreeing that any property sales would be at or above their appraised values as of 2014. As of September 30, 2025, the value of the remaining unsold properties exceeded the respective 2014 appraised values, indicating compliance with the settlement terms.
• **General Legal Proceedings:** In the normal course of business, the company is a party to various legal proceedings. Management considers that any loss resulting from such proceedings individually or in the aggregate will not be material to the company's financial condition or results of operations.

Related Party Transactions

• The company has a Consolidated Lease Agreement with a not-for-profit organization where the company's Chairman, Paul Lamb, serves as Chairman and a director. This lease, extended to December 2027 with a 3% annual escalator, is below market rate, generating $8,829 annually and $44,144 over the extended period. Independent members of the Board approved the transaction. Paul Lamb's firm, LambZankel, LLP, provided pro bono legal representation to the not-for-profit on the lease. Paul Lamb will no longer be a director after November 5, 2025.

Stakeholder Impact

• **Shareholders:** Expected to receive higher estimated liquidating distributions ($14.72/share) compared to the previous period, but the timeline for these distributions has been extended to December 31, 2027, or potentially later. The resolution of the proxy contest with Star Equity Fund, LP, and changes to the Retention Bonus Plan aim to align management and director interests with shareholders.
• **Employees:** Retention bonus plan benefits are now generally not payable until liquidating cash distributions are paid to shareholders, with modified bonus rates tied to property sales. This aligns employee incentives with the successful completion of the liquidation.
• **Customers (Tenants):** The company continues to manage its real estate portfolio, executing new leases and renewals, which provides stability for existing tenants. However, the ultimate liquidation plan means properties will eventually be sold, potentially impacting long-term tenancy.
• **Creditors:** The company aims to settle all debts and claims from asset sale proceeds. The extension of the liquidation timeline and efforts to modify loan terms indicate a proactive approach to managing liabilities, but the inherent uncertainties of liquidation could affect the timing and certainty of payments.
• **Local Communities/Regulatory Bodies:** The ongoing entitlement efforts and legal proceedings (Article 78) highlight the significant interaction and potential impact on local communities and regulatory bodies in Smithtown and Cortlandt Manor, New York, regarding land use and environmental concerns.

Next Steps

• Continue vigorous defense against the Article 78 Proceeding and any further appeals related to the Flowerfield Subdivision Application.
• Pursue subdivision and site plan approvals for the Flowerfield property, with an expected approval in Q1 2026.
• Pursue subdivision approval for the Cortlandt Manor property, with an expected approval in 2027.
• Work towards the closing of the B2K Agreement for the Flowerfield parcel, estimated by December 2027 or August 2028.
• Seek modifications to existing loan facilities to extend maturity dates and strengthen financial position through the extended liquidation period.
• Continue national marketing campaign with JLL for the sale of remaining Flowerfield and Cortlandt Manor properties.
• Manage cash flow from tenant leases and maintain/improve occupancy rates.
• Evaluate estimates and assumptions for liquidation costs and asset values on an ongoing basis.

Key Dates

Recommendation

The company is in a liquidation phase, and the primary value driver is the successful sale of its remaining real estate assets. While the estimated distribution per share has increased and a significant sale agreement is in place, the liquidation timeline has been extended, and substantial legal and regulatory hurdles remain. The resolution of the proxy contest provides some stability, but macroeconomic headwinds in the real estate market introduce further uncertainty. Given the extended timeline and ongoing risks, a 'hold' recommendation is appropriate for existing investors, as the upside is tied to the successful execution of the liquidation plan, which is still several years out and subject to contingencies. New investors might find the illiquid nature and long-term, uncertain payout less attractive compared to actively operating companies.

Keywords

Real Estate Liquidation, Property Development, SEC Filing, 10-Q, Gyrodyne, Flowerfield, Cortlandt Manor, Land Entitlements, Real Estate Sales, Shareholder Distributions, Legal Proceedings, Article 78 Proceeding, Commercial Real Estate, Medical Office Properties, Corporate Governance, Activist Investor, Star Equity Fund, New York Real Estate